CLAIM #50352 · PM (PM) · 2025Q3 earnings call · Oct 21, 2025 · due Dec 31, 2025
“We expect a nice acceleration in adjusted AMS growth in Q4.”
Emmanuel Babeau · CFO
In context
“latory development in Poland. Strong year-to-date volume momentum, including an improved pods to kit ratio driven by repeat purchase, drove increasing operating leverage and scale benefit enhancing profitability. Reviewing now by geography, Europe is the most developed multi-category region with markets such as Italy, Greece, Spain and Romania posting excellent growth within all three smoke-free categories. IQOS continued its strong growth trajectory in Q3, with adjusted IMS up plus 7.3% against a tougher comparison, notably driven by Italy, and supported by innovation on new terrier variants and Livia capsules. PMI HTU shares of the combined cigarette and HTU HTU industry increased by plus 1.2 points to 10.7% with key cities such as Munich, Rome and Madrid all posting very strong growth. We expect a nice acceleration in adjusted AMS growth in Q4. After numerous launches and expansions across the region in the last one to two years, ZYN's excellent early traction continued with share gains across market, including Poland, Switzerland, Greece, and The UK. Within e-vapor, the consumer shift to closed spot continued to underpin growth. These volumes doubled, with the brand now holding the number one post position in seven European markets. In Japan, IQOS continues to grow very robustly, with Q3 adjusted IMS growth of plus 6% again against a strong plus 14% in Q3 last year, and plus 7.6% on a year-to-date basis. This primarily reflects the category growth rate, with twelve month segment share stable at around 70%, notwithstanding a very significant step up in competitive commercial investment and intensity and, as in similar periods in”
Verify independently
SEC filings for PM ↗ · Claim quote is verbatim from the 2025Q3 earnings call.